Skip to Main Content

Paper Details

Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer.
Cancer Med
33
2021
BRAF GA, BRCA1, BRCA1/2, CD274, ERBB2, ERBB2 short variant, ERneg, ERpos, GA, HER2amp, HER2neg, ICPI, MBC, MBCs, MDM2, MTOR, Metastatic Breast Cancer, PBRM1, PBRM1 GA, PD-L1, PD-L1 SP142, STK11, TNBC, immunocytes, metastatic breast cancers, patients, triple-negative breast cancer, tumor
Author NameAffiliation
Jonathan K KillianFoundation Medicine
Jonathan K KillianFoundation Medicine
Jonathan K KillianFoundation Medicine
Jonathan K KillianFoundation Medicine
Shakti H RamkissoonFoundation Medicine
Shakti H RamkissoonWake Forest Comprehensive Cancer Center and Department of Pathology, Wake Forest School of Medicine
Shakti H RamkissoonFoundation Medicine
Jeffrey S RossUpstate Medical University
Jeffrey S RossFoundation Medicine
Jeffrey S RossFoundation Medicine
  • 1 - 10

Datasets

Release 1.2